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Clinical question: Is there evidence that hip protectors and vitamin D with calcium 
supplementation reduce hip fractures in the elderly?
Results: The results are that vitamin D and calcium supplementation reduce incidence of hip 
fractures. Hip protectors provide some benefit in reducing hip fractures in elderly patients in 
residential facilities.
Implementation: Primary care providers should assess patients for the risk of hip fracture 
and consider using hip protectors and nutritional supplementaton in selected individuals to 
prevent fractures.
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Hip fractures
Definition: The term ‘hip fractures’ encompasses five subtypes of fractures of the 
proximal femur: femoral head, femoral neck, intertrochanteric, trochanteric, and 
subtrochanteric. This is a common orthopedic emergency with ∼1.7 million hip 
fractures occurring annually worldwide. Due to the aging population, it is estimated 
that by 2050, there will be 6.26 million hip fractures worldwide.1
Etiology: The vast majority of hip fractures afflicts the elderly and generally occurs with 
low mechanism injuries, such as falls from standing. Osteoporosis is the predominant 
risk factor. However, the risk of hip fracture is also much higher for elders in residential 
dwellings when compared to those in the community. This is in part because more 
debilitated elders are both more likely to fall and more likely to have lost mechanisms 
to protect themselves during a fall. The term ‘residential’ elder refers to those elderly 
patients who are housed in nursing homes or assisted living facilities, in contradistinction 
to ‘community-dwelling’ elders who reside outside of such institutions.
Economics: Hip fractures are associated with significant morbidity and mortality and 
impose a large economic burden. In the United States, the average cost for inpatient 
hip fracture care is $26,000 per episode. There is also significant cost attributable to the 
disability of hip fractures, largely related to skilled nursing care. Few patients regain 
their former level of independence after sustaining a hip fracture, and mortality rates at 
1 year have been reported at 10%–20%.2 The lifetime attributable cost of hip fractures 
has been estimated to be $81,000 per person in the United States. The projected annual 
cost of hip fractures in the United States is $16 billion in 2020. Worldwide, the direct 





Level of evidence used in this summary: Systematic 
reviews, meta-analyses, and randomized controlled trials 
(RCTs) were analyzed.
Search sources: The search engines used for this study were 
PubMed, Cochrane library, NHS evidence, HTA database, 
and DARE.
Outcomes: From the patient perspective, the main out-
comes are:
1. Decreased incidence of hip fractures
2. Compliance with intervention
3. Occurrence of complications with the intervention
Consumer summary: Hip fractures usually occur in the 
elderly after suffering a minor fall. Osteoporosis is the main risk 
factor for hip fractures. Therefore, prevention of hip fractures 
should naturally focus on prevention of falls and osteoporosis, 
as well as reducing the risk of fracture resultant from a fall. 
The two common recommended preventative measures are 
reviewed. There is good evidence that vitamin D plus calcium 
supplementation are preventative against hip fractures and 
some evidence that hip protectors can also be preventative in 
certain groups of high-risk elders. Although this article does not 
address other measures, such as bisphosphonates or estrogen 
replacement therapy, these may be beneficial and should also 
be considered for patients at risk for osteoporosis.
The evidence
Table 1 The two most recent RCTs with conflicting results10,11
Author Population No. enrolled Compliance Conclusion
Koike, et a111 High-risk residential elders 672 79.7% Hip protectors effective at reducing 
hip fractures in high-risk patients
Kiel, et a110 nursing home residents 531 73.8% Ineffective at preventing hip fractures
Do hip protectors reduce the incidence 
of hip fractures after a fall?
Systematic reviews:  3
Meta-analysis:  1
RCTs:  2
In biomechanical studies, hip protectors (hard more 
so than soft) have been shown to reduce the peak pressure 
upon the hip during falls.4,5 However, in clinical trials, hip 
protectors have only been shown to be of modest benefit in 
the reduction of hip fractures. The more robust results come 
from data of nursing home residents and those at higher risk 
for fracture.
The Cochrane systematic review concluded that hip pro-
tectors marginally diminish the risk of hip fracture in nursing 
and residential care settings (4.2% vs 6.2%; relative risk 
[RR], 0.77; 95% confidence intervals [CI]: 0.62–0.97), but 
not in community-dwelling elders (3.5% vs 2.8%; RR, 1.16; 
95% CI: 0.85–1.59).6 Two other systematic reviews reached 
similar conclusions, namely, that hip protectors significantly 
reduce the risk of hip fracture in nursing homes. The authors 
recommended use of hip protectors for residential-dwelling 
elders.7,8
The meta-analysis by Sawka et al reached similar 
conclusions regarding effectiveness of hip protectors and 
was later included in the 2010 systematic review by the 
same author.8,9
The two most recent RCTs, with conflicting results, are 
shown in Table 1.10,11
Lack of adherence to the therapy continues to be a lim-
iting factor, and it is more pronounced outside of nursing 
home settings. Up to 70% of both community and residential 
elders are not compliant at follow-up, although the adher-
ence figures are highly variable between studies. The most 
commonly reported complications with hip protectors are 
skin irritation and lack of comfort, as well as increased need 
for nursing care.
Conclusion
Hip protectors are helpful to reduce incidence of hip fractures 
in residential, high-risk patients. Community elders do not 
benefit from the use of hip protectors. Overall, there is poor 
adherence to this intervention. Most common complications 
are skin irritation and discomfort.
Does vitamin D and calcium 
supplementation reduce the risk of hip 
fracture?
Systematic reviews:  4




reducing hip fractures in elderly
population. No effect was found with low-dose vitamin D 
supplementation in any of the trials reviewed.8,13,14
A high-powered meta-analysis of 29 randomized trials 
(63,897 participants) examining calcium supplementation 
found a 12% risk reduction of any type of fracture, including 
hip fractures.15 This effect was more pronounced in older 
patients (70 years), those with lower body weight, and those 
elders in residential dwelling. The treatment effect was bigger 
with high-dose calcium supplementation (1200 mg/day) 
and with high vitamin D doses (800 IU/day). Interestingly, 
the treatment was shown to be similarly effective with use of 
calcium alone as with calcium in combination with vitamin D. 
The protective effect was found to be greater in studies with 
high compliance. Except for one recent meta-analysis, those 
that were reviewed concluded that vitamin D plus calcium 
was superior to vitamin D alone.15–18
Table 2 summarizes the systematic reviews and recent 
meta-analyses of vitamin D alone versus vitamin and calcium 
supplementation for prevention of hip fractures.
The most commonly reported side effects from the use 
of vitamin D and calcium are gastrointestinal symptoms, 
Extensive analyses have been carried out examining the 
effect of vitamin D, with or without calcium supplementation, 
in prevention of hip fractures. Although the evidence is not 
consistent, there seems to be a beneficial effect to high-dose 
vitamin D supplementation, especially when combined with 
calcium. The current National Institutes of Health daily intake 
recommendations are 400 international units (IU) (51–70 
years) or 600 IU (70 years) of vitamin D and 1200 mg of 
calcium (51 years).
The largest systematic review looked at 45 randomized 
trials in total. This systematic review concluded, on the basis 
of nine trials (24,749 participants), that vitamin D alone is 
not likely to be effective in preventing hip fractures. However, 
based on eight trials (445,658 participants), vitamin D 
plus calcium (when compared to placebo) demonstrated 
a significant reduction in the incidence of hip fractures. 
Similarly, regarding hip protectors, they also concluded that 
residential-dwelling elders derived the most benefit.12
The three other systematic reviews concluded that high-
dose vitamin D was beneficial with greatest benefit derived 
when supplemented with calcium and in a residential elderly 
Table 2 Summary of systematic reviews and recent meta-analyses of vitamin D alone versus vitamin and calcium supplementation for 
prevention of hip fractures
Author Type Vitamin D alone Vitamin D 
and Calcium
Conclusion
Avenell, et al12 review of 45 
rTCs
Not beneficial Beneficial recommend combined vitamin D and calcium 
supplementation in frail older people in 
institutions. Unclear effect on community dwellers
Izaks, et al14 review of 11 
rCTs
Not beneficial  
(low dose)
Beneficial vitamin D (high dose) and calcium showed 
decreased fracture risk in institutionalized 
patients. Low dose vitamin D is ineffective, and 
there is not sufficient data on high dose vitamin D 
alone
MacLean, et al13 review of 7 rCTs Beneficial Beneficial vitamin D with or without calcium 
supplementation reduces risk of nonvertebral 
fractures. One study of calcium supplementation 
alone showed no effect
Sawka, et al9 review of 7 rCTs Beneficial Beneficial High dose vitamin D supplementation with or 
without calcium reduces risk of hip fracture
Tang, et al15 Meta-analysis of 
29 rCTs
not investigated Beneficial Calcium alone or in combination with vitamin D 
is effective at preventing fractures. Both are more 
effective in high doses
Bischoff-Ferrari, 
et al16
review of 7 rCTs Unable to determine Beneficial High dose vitamin D supplementation with calcium 
reduces risk of hip and nonvertebral fracture in 
community and institutionalized settings
Jackson, et al17 Meta-analysis of 9 
rCTs
Not beneficial Not beneficial Though no statistically significant fracture 
reduction demonstrated, there was a trend 
toward reduced risk
Bergmana, et al18 Meta-analysis of 8 
rCTs
not investigated Beneficial vitamin D3 and calcium supplementation reduced 





renal disease, and hypercalcemia. All of these were 
modestly but significantly increased in patients receiving 
treatment versus placebo. According to the systematic 
review by the Cochrane Collaboration, related vitamin D 
compounds used do not seem to have advantages when 
compared to vitamin D, and calcitriol, specifically, may 
be deleterious through an increase of documented adverse 
events.
Conclusion
High-dose vitamin D (800 IU) and calcium (1200 mg) in 
combination are effective at reducing risk of hip fracture, 
The practice
•	 In this article, we addressed two commonly utilized 
methods of hip fracture prevention. There are many 
more options available for prevention of osteoporosis 
and secondarily hip fractures, including bisphosphonates 
and estrogen modulators. These therapies were beyond 
the scope of this review; further reading on these topics 
is recommended below.
Indications for specialist referral
Preventative measures for osteoporosis and hip fractures can 
be instituted by primary care physicians and do not require 
specialist referral.
Further reading
Cranney A, Guyatt G, Griffith L, et al. Meta-analyses of therapies for post-
menopausal osteoporosis. IX: Summary of meta-analyses of therapies for 
postmenopausal osteoporosis.  Endocr Rev. 2002 Aug;23(4):570-8.
Lewiecki EM. Prevention and treatment of postmenopausal osteoporosis. 
Obstet Gynecol Clin North Am. 2008;35(2):301–315, ix. 
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especially in institutionalized elderly patients. Adverse 
events, though rare, can include hypercalcemia and renal 
disease.
Potential pitfalls
•	 Monitor patients for side effects of treatments, such as skin 
irritation in the case of hip protectors or hypercalcemia 
and renal disease in the case of vitamin D and calcium 
supplementation.
•	 Monitor and control risk factors for osteoporosis.
•	 Do not fail to recognize reasons for fracture other than 
osteoporosis, such as elder abuse or pathologic fracture.
•	 Investigate cause of frequent falls.
•	 Recognize the high morbidity and mortality of 
osteoporotic fractures.
Management
Primary providers should screen for both risk factors for 
osteoporosis and the disease itself, including bone density 
screening. Consider vitamin D and calcium supplementa-
tion in high-risk individuals. Hip protectors should be 
considered for residential elders and those at high-risk of 
hip fracture.
Assessment
Screen for risk factors for osteoporosis (such as tobacco use, 
low body weight, high alcohol intake, use of steroids, and 
physical inactivity) and for falls (such as alcohol or substance 
abuse, underlying medical conditions, poor mobility, vision, 
cognition, and unsafe environments). Interventions should 
also be aimed at reduction of these risk factors.
Treatment
•	 Dose vitamin D at 800 IU per day and calcium at 1200 mg 
per day.
•	 Hip protectors may be obtained from numerous com-
mercial vendors. They are available in a variety of styles 
and sizes, including specific models designed for elders 
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